Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Cellular and molecular life sciences : CMLS - 1 Feb 2008

Ibraghimov-Beskrovnaya O, Bukanov N

Abstract excerpt

Polycystic kidney diseases (PKDs) represent a large group of progressive renal disorders characterized by the development of renal cysts leading to end-stage renal disease. Enormous strides have been made in understanding the pathogenesis of PKDs and the development of new therapies. Studies of autosomal dominant and recessive polycystic kidney diseases converge on molecular mechanisms of cystogenesis, including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion
Share to Cell Cycle
Share to Kidney Failure, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polycystic Kidney, Autosomal Dominant

Share to Polycystic Kidney Diseases

Share to Protein Conformation

Share to Receptors, Cell Surface

Share to TRPP Cation Channels

Source

Open in PubMed Open full text

Identifiers

PMID: 17975706
DOI: 10.1007/s00018-007-7362-x
PMCID: PMC2775119

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.PMID 17975706Read ↗

[Recent advances in molecular pathogenesis and treatment of polycystic kidney disease].Semantic proximity Read ↗

Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.Semantic proximity Read ↗

Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.Semantic proximity Read ↗

Polycystic Kidney DiseaseSemantic proximity Read ↗

Targeting new cellular disease pathways in autosomal dominant polycystic kidney diseaseSemantic proximity Read ↗

Genetics and Pathogenesis of Polycystic Kidney DiseaseSemantic proximity Read ↗

Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions.Semantic proximity Read ↗

Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.Semantic proximity Read ↗

[Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].Semantic proximity Read ↗

Insights Into the Molecular Mechanisms of Polycystic Kidney DiseasesSemantic proximity Read ↗

The cell biology of polycystic kidney diseaseSemantic proximity Read ↗

mTOR signaling in polycystic kidney disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.